Zhejiang Hisoar Pharmaceutical Stock Cash Per Share

Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

In accordance with the recently published financial statements, Zhejiang Hisoar Pharmaceutical has a Cash Per Share of 0.0 times. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).

The Macroaxis Fundamental Analysis modules help investors analyze Zhejiang Hisoar Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhejiang Hisoar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhejiang Hisoar Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Zhejiang Hisoar financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang Hisoar security.